SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 483,335.18 |
Enterprise Value ($M) | 499,679.68 |
Book Value ($M) | 11,149.30 |
Book Value / Share | 12.40 |
Price / Book | 43.35 |
NCAV ($M) | -22,333.10 |
NCAV / Share | -24.83 |
Price / NCAV | -21.64 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.22 |
Return on Assets (ROA) | 0.14 |
Return on Equity (ROE) | 0.75 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.87 |
Current Ratio | 1.13 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 21,331.60 |
Assets | 54,814.00 |
Liabilities | 43,664.70 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Pnc Financial Services Group, Inc. | 5.25 | -0.11 | |
13G/A | Vanguard Group Inc | 7.73 | 6.02 | |
13G/A | BlackRock Inc. | 6.90 | 2.49 | |
13G/A | Lilly Endowment Inc | 10.83 | -4.20 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
343,867 | 2,967,708 | 11.59 | |
295,244 | 2,178,763 | 13.55 | |
303,934 | 2,004,174 | 15.17 | |
273,796 | 1,864,471 | 14.68 | |
(click for more detail) |
Financial data and stock pages provided by
Fintel.io